Biotech News

GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®

GoodRx (GDRX)GoodRx2026-03-06 14:00 ESTCompany update

GoodRx Employer Direct enables self-insured employers to subsidize the $449 Lilly Employer Connect medication price for Zepbound KwikPen to reduce employee out-of-pocket costs Brief Summary: GoodRx to collaborate with Eli Lilly to expand employer-sponsored access to Zepbound® KwikPen®, an

Open original release

Related news

GoodRx

GoodRx is a consumer healthcare platform focused on drug pricing, pharmacy access, and savings tools for patients.

Recent company news

Stock data

Close
2.87 USD
Market cap
999.09M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States